Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SFINX study of sugammadex and postoperative alertness after ambulatory surgery
NL-OMON36651Phase 4Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2011
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of Sugammadex in Postoperative recovery disorder (3 arms), sponsored by Radboud University Medical Center. Primary endpoints: Modified Aldrete score, Trail Making Test Part A and 2 more. Started Dec 2011; status: recruiting.
02
Drugs
Sugammadex
03
Conditions
Postoperative recovery disorder
Beyond the preview
Go deeper on NL-OMON36651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36651.